View Amendment Current Amendment: H-3824.docx to Bill 3824     The Committee on Medical Affairs proposed the following amendment (H-3824):
    Amend the bill, as and if amended, page 2 by striking lines 34-39 and inserting:
/         (4)     a practitioner approving the administration of a Schedule II controlled substance by a healthcare provider licensed in South Carolina;
        (5)     a practitioner prescribing a Schedule II controlled substance for a patient in a skilled nursing facility, nursing home, community residential care facility, or an assisted living facility and the patient's medications are stored, given and monitored by staff; or                                                                                     /

Amend the bill further, page 3, by striking lines 15-38 and inserting:
/         "Section 44-53-1630.         As used in this section article:
    (1)     'Authorized delegate' means an individual who is approved as having access to the prescription monitoring program and who is directly supervised by an authorized practitioner or pharmacist.
    (2)     'Controlled substances' means those substances listed in Schedules II, III, and IV of the schedules provided for in Sections 44-53-210, 44-53-230, 44-53-250, and 44-53-270.
    (2)(3)     'Dispenser' means a person who delivers a Schedule II-IV controlled substance to the ultimate user, but does not include:
        (a)     a licensed hospital pharmacy that distributes controlled substances for the purpose of inpatient hospital care or dispenses prescriptions for controlled substances at the time of discharge from the hospital;
        (b)     a practitioner or other authorized person who administers these controlled substances; or
        (c)     a wholesale distributor of a Schedule II-IV controlled substance.
    (3)(4)     'Drug control' means the Department of Health and Environmental Control, Bureau of Drug Control.
    (4)(5)     'Patient' means the person or animal who is the ultimate user of a drug for whom a prescription is issued or for whom a drug is dispensed, or both.
    (5)(6)     'Practitioner' means an individual authorized pursuant to state and federal law to prescribe controlled
substances."                                                     /

Amend the bill further, page 5 by striking lines 12-20 and inserting:
/             "Section 40-15-145.     As part of the biennial continuing education required by the board or pursuant to law, including Regulation 39-5, South Carolina Code of State Regulations, a dentist authorized pursuant to state and federal law to prescribe controlled substances shall complete at least two hours of continuing education every two years related to approved procedures of prescribing and monitoring controlled substances listed in Schedules II, III, and IV of the schedules provided for in Sections 44-53-210, 44-53-230, and 44-53-250."                     /

Amend the bill further, page 6, by striking lines 1-9 and inserting:
/             "(3)     every two years, the physician assistant shall provide documentation of four continuing education contact hours in prescribing controlled substances acceptable to the board related to approved procedures of prescribing and monitoring controlled substances listed in Schedules II, III, and IV of the schedules provided for in Sections 44-53-210, 44-53-230, and 44-53-250;"                                                                         /

Amend the bill further page 6, by striking lines 14-37 and inserting:
/         "Section 40-51-140.     A person licensed to practice podiatry must pay an annual a biennial renewal license fee which must be established in regulation by the board, annually biennially must complete twelve twenty-four hours of continuing medical education through a program approved by the South Carolina Board of Podiatry Examiners, and must submit documentation to the board of completion of this education. If a podiatrist is authorized pursuant to state and federal law to prescribe controlled substances, two of the requisite biennial hours of continuing education must be related to approved procedures of prescribing and monitoring controlled substances listed in Schedules II, III, and IV of the schedules provided for in Sections 44-53-210, 44-53-230, and 44-53-250. If the renewal fee is not accompanied with the appropriate continuing education documentation, the license may not be renewed and is considered late and subject to the penalties promulgated by the board in regulation. This continuing education requirement takes effect and applies to licenses being renewed beginning in 1997. If the renewal fee is not paid within two months after the date of notification by the secretary department that the fee is due, the license of the person failing to pay shall be considered late and a penalty imposed as determined by regulation. After an additional sixty days a nonrenewed license must be suspended or revoked and must be reissued only by a majority vote of the Board of Podiatry Examiners and upon payment of a late fee and penalties established by the board."/

Amend the bill further, page 6 by striking lines 42-43 and page 7 by striking lines 1-10 and inserting:
/         "(B)     Each licensed pharmacist, as a condition of an active status license renewal, shall complete fifteen hours (1.5 CEU's) of American Council on Pharmaceutical Education (ACPE) accredited continuing pharmacy education or continuing medical education (CME), Category I, or both, each license year. Of the fifteen hours, a minimum of six hours must be obtained through attendance at lectures, seminars, or workshops. At least fifty percent of the total number of hours required must be in drug therapy or patient management. and at least one hour must be related to approved procedures for monitoring controlled substances listed in Schedules II, III and IV of the schedules provided for in Sections 44-53-210, 44-53-230, and 44-53-250."                                 /

    Renumber sections to conform.
    Amend title to conform.